Study for people with an Aveir DR leadless pacemaker
Part of Brain & nervous system, Heart & circulation clinical trials.
This study uses your medical records from Medicare to learn how the Aveir DR leadless pacemaker performs in everyday life after it’s implanted. It mainly helps researchers and doctors understand real-world outcomes and care needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an Aveir DR leadless pacemaker implanted
- You were enrolled in Medicare Part A and Part B for the 12 months before your implant
- You can be enrolled in Medicare Part A and Part B for 30 days after the implant (unless you died within those 30 days)
- You are able to share/link your Medicare fee-for-service data with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows Medicare patients who recently got a specific type of pacemaker to see how coverage works in real life. It may help ensure patients continue to have access to the devices and care they need.
This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.
This study looks at Medicare claims to understand how well different pacemakers work in real-world care after they are implanted. You may be included if you are a Medicare patient who received an Aveir VR leadless pacemaker or a single-chamber ventricular pacemaker after the study began.
This study is an observational registry for people who have or will receive an AVEIR leadless pacemaker. It collects information to help doctors understand how the device performs over time.
This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.
This trial is testing a new type of single-chamber pacemaker (called ALPs) for people who need a pacemaker due to a slow heart rate (heart block), often with atrial fibrillation. It's a leadless device that is placed directly inside the heart, avoiding the need for wires.
Hear when a new Cardiac Pacemaker trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.